NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device
Recent FDA Approval and Market Reaction NeurAxis’s Oct. 24, 2025 announcement of FDA 510(k) clearance for its PENFS device immediately grabbed market attention. The clearance authorizes use in adults (8 years and